AU8298298A - Use of submicron oil-in-water emulsions with dna vaccines - Google Patents

Use of submicron oil-in-water emulsions with dna vaccines

Info

Publication number
AU8298298A
AU8298298A AU82982/98A AU8298298A AU8298298A AU 8298298 A AU8298298 A AU 8298298A AU 82982/98 A AU82982/98 A AU 82982/98A AU 8298298 A AU8298298 A AU 8298298A AU 8298298 A AU8298298 A AU 8298298A
Authority
AU
Australia
Prior art keywords
water emulsions
dna vaccines
submicron oil
submicron
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82982/98A
Inventor
Douglas J. Jolly
James E. Mccormak
Gary Van Nest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU8298298A publication Critical patent/AU8298298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU82982/98A 1997-07-08 1998-07-08 Use of submicron oil-in-water emulsions with dna vaccines Abandoned AU8298298A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5194497P 1997-07-08 1997-07-08
US60051944 1997-07-08
US5475697P 1997-08-05 1997-08-05
US60054756 1997-08-05
PCT/US1998/014310 WO1999002132A2 (en) 1997-07-08 1998-07-08 Use of submicron oil-in-water emulsions with dna vaccines

Publications (1)

Publication Number Publication Date
AU8298298A true AU8298298A (en) 1999-02-08

Family

ID=26729981

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82982/98A Abandoned AU8298298A (en) 1997-07-08 1998-07-08 Use of submicron oil-in-water emulsions with dna vaccines

Country Status (5)

Country Link
EP (1) EP1006999A2 (en)
JP (1) JP2002509545A (en)
AU (1) AU8298298A (en)
CA (1) CA2295740A1 (en)
WO (1) WO1999002132A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2689696C (en) * 1999-02-26 2013-08-06 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
ID30407A (en) 1999-05-13 2001-11-29 American Cyanamid Co COMBINATION FORM FOR ADDITION MATERIALS
AR045702A1 (en) * 2001-10-03 2005-11-09 Chiron Corp COMPOSITIONS OF ASSISTANTS.
GB0622282D0 (en) 2006-11-08 2006-12-20 Novartis Ag Quality control methods
WO2009120811A1 (en) * 2008-03-25 2009-10-01 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
GB0822001D0 (en) * 2008-12-02 2009-01-07 Glaxosmithkline Biolog Sa Vaccine
AR080810A1 (en) * 2010-03-29 2012-05-09 Novartis Ag COMPOSITION OF A PEPTIDE TO BETA1-6 LINKED TO A VIRUS, VACCINE AND USE TYPE
JP6025721B2 (en) 2010-07-06 2016-11-16 ノバルティス アーゲー Cationic oil-in-water emulsion
ES2702318T3 (en) 2011-07-06 2019-02-28 Glaxosmithkline Biologicals Sa Cationic emulsions of oil in water
RU2606846C2 (en) 2011-07-06 2017-01-10 Новартис Аг Emulsions of “oil-in-water” type, which contain nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0832638B2 (en) * 1989-05-25 1996-03-29 カイロン コーポレイション Adjuvant formulation comprising submicron oil droplet emulsion
AU675702B2 (en) * 1993-01-26 1997-02-13 Leslie R. Coney Compositions and methods for delivery of genetic material
AU2656295A (en) * 1994-06-02 1996-01-04 Chiron Corporation Nucleic acid immunization using a virus-based infection/transfection system

Also Published As

Publication number Publication date
EP1006999A2 (en) 2000-06-14
JP2002509545A (en) 2002-03-26
WO1999002132A3 (en) 1999-08-12
CA2295740A1 (en) 1999-01-21
WO1999002132A2 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU2790797A (en) Oil-in-water emulsified composition and oil-in-water emulsifying agent
AU7538398A (en) Emulsion for well and formation treatment
AU6347994A (en) Silicone containing oil-in-water emulsions
AU7483698A (en) Multi-element fluid delivery apparatus and methods
AU8766098A (en) Assay methods and apparatus
AU1931899A (en) Optoacoustic contrast agents and methods for their use
AU3984097A (en) Emulsifier blends for oil-in-water emulsions
HK1046503A1 (en) Oil-in-water emulsion with improved stability
AU6266798A (en) Disposable multi-sampler and fitment
HUP0000501A2 (en) Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin
PL338183A1 (en) Decorative cosmetic oil-in-water emulsion
AU2838195A (en) Demulsifier for water-in-oil emulsions, and method of use
AU8298298A (en) Use of submicron oil-in-water emulsions with dna vaccines
AU6941698A (en) Anti-cancer vaccine
AU5874798A (en) Vaccination methods and molecules
AU7430698A (en) Fat emulsions
AU7597998A (en) Herpes simplex virus vp22 vaccines and methods of use
AU3979395A (en) DNA sequences and their use
AU6771998A (en) Identification of the progression elevated gene-3 and uses thereof
AU6084499A (en) Self-emulsifying water-in-oil emulsion bases
AU8408998A (en) Assay for total and direct bilirubin
AU1538895A (en) Anti-allergic vaccine
AU6975996A (en) Stabilized agchemical concentrate and use thereof
AU6613598A (en) Fuel-water emulsions
EP0784972A3 (en) Cosmetic and/or pharmaceutical emulsions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase